Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(1012)
•••
Comment by investclubon Feb 01, 2020 4:11pm
134 Views
Post# 30629614

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA IND NEWS!!!!!!!!!!!!!!!!!!

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA IND NEWS!!!!!!!!!!!!!!!!!!Hempdoc wrote

 

investclub wrote: True enough LaserStock29 some things may get moved further out but by them getting things done now rather then at the time of approval accelerates the time line hopefully making less time lost   .....   besides this little delay gives me a chance to read articles and go over notes of interest 

 

 

  Hey Investclub...appreciate your input.  Can you cite any FDA source re: a sponsor's ability to proceed with new site training during a clinical hold (a hold that is placed prior to trial initiation vs a hold or suspension of an ongoing trial)?  Could not find info on this....thanks.

Hi Hempdoc...  no I give up everything is hold during clinical trial usually because of adverse reaction to the drug being tested if you can find anything then you have full bragging rights for 1 week and my admiration. Ok so if Theralase is training then they must have been giving the go-ahead for training only by FDA as long as it didn't involve patients. A difficulty I encountered was almost everything I came upon had toxins or bad side affects .... boy oh boy Theralase is looking like they are at the winner's circle already.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities